In this respect the previous observation in hematologic cancers that B4GALT1 is responsible for drug resistance by regulating the expression of P-gp and MDR- associated protein [52,69] acquires particular relevance given the known ability of CSCs to be drug resistant [71,72]. The gene discussed is B4GALT1; the disease is hematopoietic and lymphoid cell neoplasm.